Teclistamab 153mg
| Product Overview | |
| Generic Name | Teclistamab 153mg |
| Brand Name(s) | Tecvayli |
| Form | IV Injection Vial |
| Strength | 153 mg/1.7 mL (90 mg/mL) |
| Therapeutic Class | Antineoplastic, immunotherapy: bispecific monoclonal antibody / T-cell engager (BCMA × CD3) |
| ATC Code | L01FX24 |
| Manufacturing & Regulatory | |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 233300EL870285 |
| Logistics & Export | |
| Shelf Life | 24 Months |
| Storage | Refrigerate 2–8 °C, protect from light |
| Incoterms | EXW/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
| CTD Summary | CTD available to regulators; summary available to qualified partners |
Description
Indicated in Relapsed or refractory multiple myeloma in adults
